Title |
Does the efficacy of parent–child training depend on maternal symptom improvement? Results from a randomized controlled trial on children and mothers both affected by attention-deficit/hyperactivity disorder (ADHD)
|
---|---|
Published in |
European Child & Adolescent Psychiatry, January 2018
|
DOI | 10.1007/s00787-018-1109-0 |
Pubmed ID | |
Authors |
Alexander Häge, Barbara Alm, Tobias Banaschewski, Katja Becker, Michael Colla, Christine Freitag, Julia Geissler, Alexander von Gontard, Erika Graf, Barbara Haack-Dees, Susann Hänig, Klaus Hennighausen, Sarah Hohmann, Christian Jacob, Charlotte Jaite, Christine Jennen-Steinmetz, Viola Kappel, Swantje Matthies, Alexandra Philipsen, Luise Poustka, Wolfgang Retz, Michael Rösler, Katja Schneider-Momm, Esther Sobanski, Timo D. Vloet, Andreas Warnke, Thomas Jans |
Abstract |
Multimodal treatment of children with ADHD often includes parent-child training (PCT). However, due to the high heritability, parents of children with ADHD are frequently also affected by the disorder, which is likely to constitute a significant barrier to successful treatment of the child. This secondary analysis of our randomized controlled multicentre AIMAC trial (ADHD in mothers and children) investigates whether children's outcomes following parent-child training in combination with maternal ADHD treatment depend on maternal symptom improvement. In a first step focusing on treatment of maternal ADHD, 144 mothers of mother-child dyads were randomized to multimodal ADHD treatment (group psychotherapy plus methylphenidate) or clinical management (mainly supportive counselling). After 12 weeks (T2), a 12-week PCT program (T2-T3) for all mother-child dyads was added to treat children's ADHD. Maternal symptomatology (CAARS-O:L; SCL-90-R) and children's externalizing symptoms (ADHD-ODD Scale, SDQ) were repeatedly assessed (T1 = baseline, T2, T3). Effects of changes in maternal symptomatology (T1-T2) on the change in children's symptom scores (T1-T3) were analysed using a general linear model, controlling for baseline scores, study centre, and maternal treatment group. 125 mother-child dyads were analysed. Mothers showed significant improvements in ADHD symptoms and overall psychopathology [CAARS-O:L ADHD index: mean - 3.54, SE 0.74 p < 0.0001; SCL-90-R Global Severity (GS): mean - 11.03, SE 3.90, p = 0.0056]. Although children's externalizing symptoms improved significantly (ADHD-ODD Scale: mean - 4.46, SE 0.58, p < 0.0001), maternal improvement had no effect on children's outcomes after Bonferroni-Holm correction for multiple testing. The findings do not support our hypothesis that children's outcomes following PCT for ADHD depend on maternal symptom improvements.Trial register CCT-ISRCTN73911400. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 117 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 16 | 14% |
Student > Ph. D. Student | 13 | 11% |
Researcher | 10 | 9% |
Student > Bachelor | 9 | 8% |
Student > Postgraduate | 8 | 7% |
Other | 18 | 15% |
Unknown | 43 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 33 | 28% |
Nursing and Health Professions | 11 | 9% |
Medicine and Dentistry | 9 | 8% |
Social Sciences | 6 | 5% |
Veterinary Science and Veterinary Medicine | 2 | 2% |
Other | 9 | 8% |
Unknown | 47 | 40% |